Prognose

Das durchschnittliche Kursziel der Analysten beträgt +0,88€(+319,05%). Der Median liegt bei +0,88€(+319,05%).

Kaufen	2
Halten	1
Verkaufen	0

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

Marijuana Stocks in Focus: U.S. Companies Ready for a Breakout
The U.S. cannabis industry continues to show impressive growth, making marijuana penny stocks a hot topic for investors this week. In 2024, legal cannabis sales reached over $32 billion across the country. That number is expected to grow past $50 billion by the end of 2025. Many states are expanding access to both medical and recreational marijuana, helping fuel this rapid expansion. In addition, recent discussions around federal reform have renewed optimism. There are growing calls to reschedule cannabis to reflect its medical use. If changes happen, they could unlock major opportunities in the market. Because of this momentum, many investors are turning their attention to low-cost marijuana stocks with high potential.» Mehr auf marijuanastocks.com
AYR Wellness Announces Changes to Management
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (“AYR” or the “Company”) (CSE: AYR.A, OTCQX: AYRWF) a leading vertically integrated U.S. multi-state cannabis operator, announced that, effective today, Steven M. Cohen has stepped down as the Interim Chief Executive Officer of the Company. The AYR board of directors (the “Board”) has appointed Scott Davido as Interim Chief Executive Officer. Mr. Cohen served as Interim Chief Executive Officer from September 18, 2024, and will remain engaged as an advisor to the Company to support this transition.» Mehr auf globenewswire.com
Top U.S. Marijuana Stocks to Watch in Q2 2025
The U.S. cannabis industry continues to show strong momentum, with projections estimating the market will reach over $45 billion in 2025. This rapid growth is fueled by expanding legalization and widespread consumer demand. Nearly half of Americans have tried cannabis, and most now live near at least one dispensary. Moreover, the industry supports hundreds of thousands of full-time jobs, making it a major contributor to the U.S. economy. However, recent headlines indicate that federal cannabis reform may be delayed. Lawmakers remain divided, and the White House has not announced any immediate plans to reschedule marijuana. Even so, optimism remains high as more states push for legalization in 2025.» Mehr auf marijuanastocks.com

Unternehmenszahlen

Im letzten Quartal hatte Ayr Wellness einen Umsatz von 109,51 Mio€ und ein Nettoeinkommen von −157,46 Mio€

(EUR)	Dez. 2024	YOY
Umsatz	+109,51 Mio	5,42%
Bruttoeinkommen	+34,45 Mio	22,88%
Nettoeinkommen	−157,46 Mio	507,55%
EBITDA	−114,36 Mio	1.136,46%

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+23,55 Mio€
Anzahl Aktien	116,77 Mio
52 Wochen-Hoch/Tief	+3,03€ - +0,10€
Dividenden	Nein
Beta	1,86
KGV (PE Ratio)	−0,07
KGWV (PEG Ratio)	0,00
KBV (PB Ratio)	+0,07
KUV (PS Ratio)	+0,05

Unternehmensprofil

Ayr Wellness Inc. ist ein vertikal integriertes Cannabisunternehmen, das in mehreren Bundesstaaten Cannabisprodukte und verpackte Markenprodukte anbaut, herstellt und verkauft. Zu den Cannabis- und Cannabisprodukten des Unternehmens gehören Konzentrate, Esswaren und Verdampferprodukte. Es bietet außerdem Verwaltungs-, Beratungs- und Betriebsunterstützungsdienste für lizenzierte Cannabisunternehmen an. Mit Stand vom 12. Mai 2022 betrieb Ayr Wellness Inc. 47 Apotheken. Das Unternehmen war früher als Ayr Strategies Inc. bekannt und änderte im Februar 2021 seinen Namen in Ayr Wellness Inc. um. Ayr Wellness Inc. wurde im Jahr 2017 gegründet und hat seinen Hauptsitz in Miami, Florida.